Global Companion Diagnostics Market By Product Type (Assays, Kits, & Reagents, Software & Services, and Instruments & Systems), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Magnetic Resonance Imaging (MRI), In Situ Hybridization (ISH), Immunohistochemistry (IHC), and Others), By Application (Oncology, Neurological Disorders, Infectious Diseases, Cardiovascular Diseases, and Others), By Sample Type (Tissue Samples, Blood Samples, and Others), By End-User (Academic & Research Centers, Reference Laboratories, Pharmaceutical & Biotechnology Companies, Hospitals & Physician Laboratories, CROs, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Global Companion Diagnostics Market size is expected to be worth around US$ 24.5 Billion by 2034 from US$ 9.1 Billion in 2024, growing at a CAGR of 10.4% during t...
